Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer
Clinical trial NCT07521605 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07521605
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-20
- Primary completion
- 2031-12-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.